These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 13340796)

  • 41. [The problem of growth stimulation in Candida albicans by antibiotics].
    MEYER-ROHN J; LANGE-BROCK T
    Arch Klin Exp Dermatol; 1957; 204(1):58-69. PubMed ID: 13403646
    [No Abstract]   [Full Text] [Related]  

  • 42. The occurrence of Candida albicans in sputum in Denmark.
    HELMS P
    J Clin Pathol; 1956 Nov; 9(4):372-3. PubMed ID: 13376741
    [No Abstract]   [Full Text] [Related]  

  • 43. Growth of Candida albicans on keratin as sole source of nitrogen.
    KAPICA L; BLANK F
    Dermatologica; 1957 Aug; 115(2):81-105. PubMed ID: 13473396
    [No Abstract]   [Full Text] [Related]  

  • 44. Slide agglutination as a presumptive test in the laboratory diagnosis of Candida albicans.
    ROSENTHAL SA; FURNARI D
    J Invest Dermatol; 1958 Nov; 31(5):251-3. PubMed ID: 13598929
    [No Abstract]   [Full Text] [Related]  

  • 45. Lethality of cell-free extract of Candida albicans for chlortetracycline-treated mice.
    ROTH FJ; MURPHY WH
    Proc Soc Exp Biol Med; 1957 Mar; 94(3):530-2. PubMed ID: 13408316
    [No Abstract]   [Full Text] [Related]  

  • 46. The GRF10 homeobox gene regulates filamentous growth in the human fungal pathogen Candida albicans.
    Ghosh AK; Wangsanut T; Fonzi WA; Rolfes RJ
    FEMS Yeast Res; 2015 Dec; 15(8):. PubMed ID: 26472755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control - An update.
    Dadar M; Tiwari R; Karthik K; Chakraborty S; Shahali Y; Dhama K
    Microb Pathog; 2018 Apr; 117():128-138. PubMed ID: 29454824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The chlamydospores of Candida albicans: comparison of three media for their induction.
    POLLACK JD; BENHAM RW
    J Lab Clin Med; 1957 Aug; 50(2):313-7. PubMed ID: 13449414
    [No Abstract]   [Full Text] [Related]  

  • 49. Experimental pathogenicity of Candida albicans and Candida dubliniensis with continuous and discontinuous fringes morphotypes.
    de Vasconcellos TC; Komiyama EY; Jorge AO; Brighenti FL; Vidotto V; Koga-Ito CY
    Mycoses; 2011 Jul; 54(4):e163-7. PubMed ID: 20337935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Identification of Candida albicans].
    ROTH W
    Schweiz Z Pathol Bakteriol; 1955; 18(5):1001-5. PubMed ID: 13311460
    [No Abstract]   [Full Text] [Related]  

  • 51. [Candida albicans].
    VALENTINCIC M
    Prir Clovek Zdravje; 1951; 6(1-2):47-8. PubMed ID: 14827846
    [No Abstract]   [Full Text] [Related]  

  • 52. Candida albicans: a study of media designed to promote chlamydospore production.
    KELLY JP; FUNIGIELLO F
    J Lab Clin Med; 1959 May; 53(5):807-9. PubMed ID: 13654924
    [No Abstract]   [Full Text] [Related]  

  • 53. Pathogenicity of Candida albicans isolates from bloodstream and mucosal candidiasis assessed in mice and Galleria mellonella.
    Frenkel M; Mandelblat M; Alastruey-Izquierdo A; Mendlovic S; Semis R; Segal E
    J Mycol Med; 2016 Mar; 26(1):1-8. PubMed ID: 26852192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weld's method for the rapid identification of Candida albicans in clinical materials.
    VOGEL RA; MOSES MR
    Tech Bull Regist Med Technol; 1957 Jun; 27(6):135-8. PubMed ID: 13486491
    [No Abstract]   [Full Text] [Related]  

  • 55. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione.
    Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B
    FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbiologic studies and preliminary clinical experiences with nystatin. I. In vitro susceptibility of Candida albicans.
    EISENBERG GM; FLIPPIN HF; WEISS W
    Antibiot Annu; 1955-1956; 3():837-41. PubMed ID: 13355372
    [No Abstract]   [Full Text] [Related]  

  • 57. Relative incidence of Candida albicans on the skins of persons with and without skin diseases.
    MARWIN RM
    J Invest Dermatol; 1949 Apr; 12(4):229-41. PubMed ID: 18126344
    [No Abstract]   [Full Text] [Related]  

  • 58. A study of methods used in the identification of Candida albicans.
    HALEY LD; STONEROD MH
    Am J Med Technol; 1955; 21(6):304-8. PubMed ID: 13268449
    [No Abstract]   [Full Text] [Related]  

  • 59. [Chemical structure and serologic properties of polysaccharide of Candida albicans].
    RZUCIDLO L; WEYMAN D; STACHOW A; RZESA G
    Med Dosw Mikrobiol; 1955; 7(3):315-22. PubMed ID: 13253270
    [No Abstract]   [Full Text] [Related]  

  • 60. The effects of beta-propiolactone on the metabolism of Candida albicans.
    GALE GR
    J Infect Dis; 1955; 96(3):250-8. PubMed ID: 14392370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.